AI-driven, real-time psychotherapy support system with diarization, transcription, NLP, and unbiased clinician insights.

Biocompatible, fast organic ion-gated transistor enabling real-time, wearable neural and electrophysiological monitoring.

Quantitative eye-head movement tracking diagnoses concussion and neurodegeneration, enabling rapid, objective tremor-based brain injury assessment.

Gene-targeted reduction of ER-MAM APP-C99 via ceramide/sphingolipid biomarkers enables early Alzheimer’s detection and therapeutic modulation.

IL-17A neutralization targets GAS-induced neuroinflammation, offering PANDAS/Sydenhams treatment potential and Th17 pathway insights.

NeuroScore AI automates transcription and scoring of cognitive test audio to quantify Alzheimer's risk, speeding, unbiased.

Hybrid, compact multi-coil and RF magnet system enhances MRI field homogeneity, boosting clinical brain imaging on standard machines.

Dual-head MRI with local shimming enables simultaneous two-subject fMRI, enhancing social interaction neuroscience and efficiency.

Biomarker-based metabolomic profiling enables early ASD identification in newborns for timely, individualized intervention.

Focused ultrasound opens the blood-brain barrier to boost peripheral extracellular vesicle release, enabling sensitive neurological biomarkers.

PDE5 inhibitors with a novel benzonaphthyridine scaffold cross the blood-brain barrier to enhance memory, aiding Alzheimer’s therapy.

Engineered probiotics produce E-cadherin peptides to block Fn attachment, lowering Fusobacterium virulence and colonization.

A holographic two-photon microscope enables simultaneous, high-resolution 3D neuronal imaging and optogenetic stimulation in vivo.

AI predicts focused ultrasound BBB openings from low-dose GBCA MRI, reducing gadolinium exposure and scan time.

Lysosomal phospholipase A2 enables BMP biosynthesis modulation to study and treat BMP-related disorders, including Niemann-Pick disease.